Send Inquiry

Request To Call Back

CEFACTAM-DS 1.5G

Name: CEFACTAM-DS 1.5G
Brand: Shivsrushti Surgimed Private Limited
Price: 55.0 INR
Availability: InStock

Price 55.0 INR/ Piece

Get a Price/Quote

MOQ : 50 Pieces

CEFACTAM-DS 1.5G Specification

Ingredients
Brand Name: CEFACTAM-DS 1.5 G Generic Name / Content: Cefoperazone & Sulbactam for Injection 1.5 g Company: Aurobindo Pharma Ltd CEFACTAM-DS 1.5 g Injection is a combination antibiotic containing Cefoperazone (a third-generation cephalosporin) and Sulbactam (a beta-lactamase inhibitor). This dual-action formulation provides broad-spectrum antibacterial activity and is effective against beta-lactamase producing bacteria. Cefoperazone inhibits bacterial cell wall synthesis, while Sulbactam prevents enzymatic degradation, enhancing overall efficacy. The formulation is designed for intravenous (IV) or intramuscular (IM) administration in hospital and clinical settings. Indications Respiratory tract infections (pneumonia, bronchitis, sinusitis) Urinary tract infections (UTIs) Skin and soft tissue infections Bone and joint infections Intra-abdominal infections Septicemia and bacteremia Gynecological infections Key Features Third-generation cephalosporin with beta-lactamase inhibitor Broad-spectrum antibacterial coverage Effective against resistant bacterial strains Sterile injectable formulation Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 1.5 g per vial Content: Cefoperazone + Sulbactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision

Quantity
50 Pieces

CEFACTAM-DS 1.5G Trade Information

Minimum Order Quantity
50 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About CEFACTAM-DS 1.5G

Brand Name: CEFACTAM-DS 1.5 G
Generic Name / Content: Cefoperazone & Sulbactam for Injection 1.5 g
Company: Aurobindo Pharma Ltd

CEFACTAM-DS 1.5 g Injection is a combination antibiotic containing Cefoperazone (a third-generation cephalosporin) and Sulbactam (a beta-lactamase inhibitor). This dual-action formulation provides broad-spectrum antibacterial activity and is effective against beta-lactamaseproducing bacteria.

Cefoperazone inhibits bacterial cell wall synthesis, while Sulbactam prevents enzymatic degradation, enhancing overall efficacy. The formulation is designed for intravenous (IV) or intramuscular (IM) administration in hospital and clinical settings.

Indications

Respiratory tract infections (pneumonia, bronchitis, sinusitis)

Urinary tract infections (UTIs)

Skin and soft tissue infections

Bone and joint infections

Intra-abdominal infections

Septicemia and bacteremia

Gynecological infections

Key Features

Third-generation cephalosporin with beta-lactamase inhibitor

Broad-spectrum antibacterial coverage

Effective against resistant bacterial strains

Sterile injectable formulation

Manufactured by Aurobindo Pharma Ltd

Dosage Form & Category

Dosage Form: Injection (Vial)

Category: Injectable / Parenteral Antibiotic

Strength: 1.5 g per vial

Content: Cefoperazone + Sulbactam

Packaging & Storage

Supplied in sterile vial packaging

Store in a cool, dry place below 25C

Protect from light

Use under qualified medical supervision

Powerful Dual-Action Antibiotic

CEFACTAM-DS 1.5G unites Cefoperazone and Sulbactam to deliver robust antibacterial activity-including effectiveness against beta-lactamase producing bacteria. Its broad-spectrum approach makes it a preferred choice for treating complex, hospital-acquired infections, ensuring patients receive comprehensive coverage even against resistant strains.

Broad Clinical Applications

This formulation is approved for a wide range of serious bacterial infections, such as respiratory tract, urinary tract, skin, soft tissue, bone, and joint infections. Its extensive efficacy also includes conditions like septicemia, intra-abdominal, and gynecological infections, providing flexibility in hospital therapy options.

Safe Administration and Handling

Each sterile vial contains 1.5 g of active ingredients meant for IV or IM administration, and should only be administered by healthcare professionals. The product must be stored below 25C, in a dry area away from direct light, to maintain its potency and safety for patient use.

FAQ's of CEFACTAM-DS 1.5G:

Q: How should CEFACTAM-DS 1.5G be administered?

A: CEFACTAM-DS 1.5G is designed for intravenous (IV) or intramuscular (IM) injection. Administration should always be performed by a qualified healthcare professional in a hospital or clinical setting.

Q: What types of infections is CEFACTAM-DS 1.5G commonly used to treat?

A: This antibiotic is indicated for treating a wide range of infections, including respiratory tract (such as pneumonia and bronchitis), urinary tract, skin and soft tissue, bone and joint, intra-abdominal, septicemia, and gynecological infections.

Q: When should I use CEFACTAM-DS 1.5G instead of other antibiotics?

A: CEFACTAM-DS 1.5G is particularly beneficial when infections are suspected or proven to involve resistant bacteria, especially those that produce beta-lactamase enzymes. Its broad-spectrum coverage makes it suitable for severe or hospital-acquired infections.

Q: Where is CEFACTAM-DS 1.5G typically supplied and used?

A: This product is supplied in sterile vials and predominantly used in hospitals or clinical settings under medical supervision. It is not intended for self-administration or over-the-counter purchase.

Q: What are the main benefits of using CEFACTAM-DS 1.5G?

A: The main advantages include its broad-spectrum antibacterial activity, effectiveness against resistant strains, and its suitability for treating severe infections. The combination of Cefoperazone and Sulbactam enhances bacterial eradication, leading to improved clinical outcomes.

Q: What is the recommended storage condition for CEFACTAM-DS 1.5G?

A: Store the vials in a cool, dry place below 25C and protect them from light. Proper storage ensures drug effectiveness and safety until administration by healthcare providers.

Tell us about your requirement